nCOVID-19
10y
Better.Be.First.
Fast patient
Proof of concept trials

PROOF OF CONCEPT TRIALS

proof of concept trials

ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.

MORE

PHASE I SPECIAL POPULATIONS

phase i special populations

ARENSIA offers exceptional fast recruitment rates for renal and hepatic impaired patients.

MORE

REGULATORY PROCESS

regulatory process

ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.

MORE

NEWS

ARENSIA begins Clinical Trial Program to test DIFFUSION’s lead drug for the treatment of hospitalized COVID-19 patients ARENSIA begins Clinical Trial Program to test DIFFUSION’s lead drug for the treatment of hospitalized COVID-19 patients 21.05.2020

We at ARENSIA are proud to announce today that we have entered into an agreement with Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) to begin a clinical trial program to test Diffusion’s lead drug trans sodium crocetinate (TSC) for the treatment...

International Clinical Trials Day International Clinical Trials Day 20.05.2020

On International Clinical Trials Day we congratulate all patients, all medical professionals and all employees involved in clinical research! Few times in history, if ever, has mankind looked at medicine with more hope and expectations for its inn...

International Nurses Day International Nurses Day 12.05.2020

They are the heart of timely data collection with the efficiency of a Swiss Clock, no matter the complexity for sample collection or processing they always make it effortlessly perfect. They are never deterred from the daily activities of coordinatin...

ARENSIA is committed to fight COVID-19! ARENSIA is committed to fight COVID-19! 23.04.2020

We are eager to bring in all our expertise and clinical research infrastructure to contribute to Phase I, II and III clinical research trials in COVID-19 patients, covering the full range of disease severity. One of ARENSIA´s Phase I researc...

World Health Day 2020 World Health Day 2020 07.04.2020

Our world changes daily in fascinating, unpredictable, positive or even dangerous ways, but it is always challenging. The COVID 19 pandemic will definitely change the way we approach health, safety and economic fragility for many years to come. By su...

e-Workshop: BUSINESS CONTINUITY STRATEGIES IN EARLY CLINICAL RESEARCH DURING THE COVID-19 PANDEMIC e-Workshop: BUSINESS CONTINUITY STRATEGIES IN EARLY CLINICAL RESEARCH DURING THE COVID-19 PANDEMIC 23.03.2020

KEEP CALM BUT KEEP MOVING: The COVID-19 pandemic is rapidly evolving worldwide with major impacts on social life, healthcare systems and the economy. Clinical Research is confronted with a series of unprecedented challenges which must be solved&nb...

Novel Coronavirus (COVID-19) Update Novel Coronavirus (COVID-19) Update 16.03.2020

Dear Partners, Thank you for the continued trust and support! Our commitment and responsibility towards our patients, employees and partners have never been stronger as we face the COVID-19 pandemic. We are continuously monitoring the “m...

Quick look behind the doors of ARENSIA´s pharmacies Quick look behind the doors of ARENSIA´s pharmacies 10.03.2020

ARENSIA has integrated pharmacies located within each of their Research Clinics. The pharmacies have been commissioned exclusively for the preparation, storage and dispensing of investigational medicinal products (IMP) for clinical trials in complian...

Defining “Controlled Environment” at ARENSIA´s Early Phase Research Clinics Defining “Controlled Environment” at ARENSIA´s Early Phase Research Clinics 28.02.2020

In a world where every variable matters we introduce the concept of Controlled Environment. In research, where even one bit of information could potentially change the outcome, we know exactly how to keep all flows of information, coming IN or OUT, u...

10 YEARS ANNIVERSARY! Message from CEO & Co-Founder Dr. Claudia Hesselmann 10 YEARS ANNIVERSARY! Message from CEO & Co-Founder Dr. Claudia Hesselmann 21.01.2020

Dear Friends!   Happy New Year to You and Your loved ones from the over 200 members of ARENSIA family around the globe: Germany, Georgia, Lithuania, Moldova, Romania, UK, Ukraine and the US!    2020 is a very special year for us. I...

ARENSIA NEWSLETTER - 1st HALF of 2019 ARENSIA NEWSLETTER - 1st HALF of 2019 09.09.2019

Dear Colleagues, Partners and Collaborators, It has been a tremendous 1st half of 2019 with some really exciting developments at ARENSIA.   Our continued dedication to complex early phase Ib/IIa studies has amounted to over 50 trials...

ARENSIA, Presents the Clinical Trials Symposium 2019, Bucharest, Romania ARENSIA, Presents the Clinical Trials Symposium 2019, Bucharest, Romania 06.09.2019

With great pleasure ARENSIA is the main corporate partner supporting the first edition of the CLINICAL TRIALS SYMPOSIUM in Romania under the patronage of the European CRO Federation and Romanian Association of CROs. As the industry expands with an...

Successful FDA Inspection at ARENSIA EXPLORATORY MEDICINE, Moldova and Georgia Successful FDA Inspection at ARENSIA EXPLORATORY MEDICINE, Moldova and Georgia 25.06.2019

Düsseldorf, Germany, 25th June, 2019 German based ARENSIA EXPLORATORY MEDICINE GmbH, a clinical research organization specialized to perform Phase Ib/IIa/PROOF OF CONCEPT clinical trials involving patients, announced today its Phase I clinica...

Our Events 2019 Our Events 2019 17.06.2019

Every year ARENSIA in a partnership with Proventa International organizes a range of events in the USA and Europe, with one goal - to share experiences about Early Clinical Trials.  Industry leaders gather for one-day round table discussions ...

ARENSIA´s Ukraine expansion ARENSIA´s Ukraine expansion 03.06.2019

As result of an exceptional start and achievements of our current dedicated clinical research unit in Ukraine, we are extremely excited to inform you that ARENSIA is expanding by opening a 2nd clinical research unit located in the downtown area of Ki...

ICH GCP Training, May 30th/31st, Bucharest, Romania ICH GCP Training, May 30th/31st, Bucharest, Romania 30.05.2019

Dear Health Care Professionals, Dear Colleagues, With great pleasure ARENSIA Exploratory Medicine invites you to attend our annual ICH-GCP training* session on 30th/31st of May 2019 at INTERCONTINENTAL HOTEL in Bucharest, Romania. Good Clinic...

Successful EMA Inspection at ARENSIA EXPLORATORY MEDICINE, Moldova Successful EMA Inspection at ARENSIA EXPLORATORY MEDICINE, Moldova 04.12.2018

ARENSIA EXPLORATORY MEDICINE GmbH, a German based clinical research organization specialized to perform Phase Ib/IIa/PROOF OF CONCEPT clinical trials involving patients, announced today, that its Phase I clinical research unit in Chisinau, Moldo...

ARENSIA Innovative Spotlight Session, November 5th, Boston, MA ARENSIA Innovative Spotlight Session, November 5th, Boston, MA 05.11.2018

We are pleased to announce ARENSIA Innovative Spotlight Session "Practical Insights and Future Visions to maximize Efficiency in Proof-Of-Concept Patient Trials", which will take place on November 5th, 2018 in Boston, MA. In today's ...

ARENSIA Innovation Workshop, September 28th, Düsseldorf, Germany ARENSIA Innovation Workshop, September 28th, Düsseldorf, Germany 28.09.2018

After last year´s success, we take pleasure to inform you that ARENSIA is organizing the 2nd Workshop focused on “Practical Insights and future visions to maximize efficiency in PROOF OF CONCEPT patient trials”. Industry leaders ...

ARENSIA Innovative Spotlight Session, May 16th, San Francisco, CA ARENSIA Innovative Spotlight Session, May 16th, San Francisco, CA 16.05.2018

We are pleased to announce ARENSIA Innovative Spotlight Session "Practical Insights and Future Visions to maximize Efficiency in Proof-Of-Concept Patient Trials", which will take place on 16th May 2018 in San Francisco, CA. In today'...

ARENSIA Spotlight Session, November 07th, Boston, MA ARENSIA Spotlight Session, November 07th, Boston, MA 07.11.2017

We are pleased to announce ARENSIA Spotlight Session "Innovative Strategies to Achieve First Efficacy Data / Proof-of-Concept in Record Time", which will take place on 7th November 2017 in Boston, MA. In today's fast-changing world, ...

ARENSIA Opening a new Clinical Research Unit for multi-therapeutic indications Kiev, Ukraine ARENSIA Opening a new Clinical Research Unit for multi-therapeutic indications Kiev, Ukraine 03.08.2017

As consequence of the increasing demand for ARENSIA´s capabilities as a specialist for early clinical trials in patients, as of August 2017, ARENSIA expands its operations with a new clinical research unit in Kiev, Ukraine. Ukraine (45 Mio. ...

ARENSIA Spotlight Session, May 24th, San Francisco, CA ARENSIA Spotlight Session, May 24th, San Francisco, CA 24.05.2017

We are pleased to announce ARENSIA Spotlight Session "Innovative Strategies to Achieve First Efficacy Data / Proof-of-Concept in Record Time", which will take place on 24th May 2017 in San Francisco, CA. In today's fast-changing worl...

2016 In Review: Message from CEO and Co-Founder Claudia Hesselmann 2016 In Review: Message from CEO and Co-Founder Claudia Hesselmann 04.01.2017

At ARENSIA, we are looking back on a very good business year, in which we were able to outdo ourselves with regard to outstanding patient enrolment rates in complex Phase 1, 2a, POC studies at our Phase 1 units in Eastern Europe. Studies involved sop...

New Phase I Unit for pediatrics studies, Bucharest, Romania New Phase I Unit for pediatrics studies, Bucharest, Romania 10.11.2015

As of August 2015, ARENSIA expands its operations with a new clinical research unit in Bucharest, Romania. This unit is fully dedicated to exploratory clinical trials Phase 1 and 2 in PEDIATRIC patients (age 0-18) with chronic and acute conditions...

VIDEO INTRO

We use technologies, such as cookies, and process personal data, such as IP addresses and cookie identifiers, to personalise content based on your interests, measure the performance of our content, and derive insights about the audiences who saw it. You can read more about our Cookie Policy here.

I accept I refuse